Disable ads (and more) with a membership for a one time $4.99 payment
Which INSTI is recommended for HIV treatment during pregnancy?
Raltegravir
Dolutegravir
Both A and B
Efavirenz
The correct answer is: Both A and B
During pregnancy, the preferred regimen for HIV treatment includes both Raltegravir and Dolutegravir. These two drugs belong to the integrase strand transfer inhibitor (INSTI) class and are considered safe and effective options for HIV treatment in pregnant individuals. Efavirenz, on the other hand, is not recommended during pregnancy due to potential teratogenic effects. Therefore, the correct answer is option C, as both Raltegravir and Dolutegravir are recommended for HIV treatment during pregnancy.